The inhibitory effect of IRAK3 following two-challenges was confirmed with meta-analyses by both in vivo and in vitro studies, and correlates to clinical outcomes, indicating the importance of IRAK3 in immunosuppression phase of sepsis. This evidence concerns the gene IRAK3 and Sepsis.